GRIBAUDO, GIORGIO
 Distribuzione geografica
Continente #
NA - Nord America 438
EU - Europa 70
AS - Asia 34
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 546
Nazione #
US - Stati Uniti d'America 437
IT - Italia 26
CN - Cina 14
SE - Svezia 12
FI - Finlandia 11
AE - Emirati Arabi Uniti 9
GB - Regno Unito 9
DE - Germania 6
JP - Giappone 5
SI - Slovenia 3
IN - India 2
TW - Taiwan 2
ZA - Sudafrica 2
BR - Brasile 1
CA - Canada 1
ES - Italia 1
EU - Europa 1
GR - Grecia 1
ID - Indonesia 1
IE - Irlanda 1
PK - Pakistan 1
Totale 546
Città #
Fairfield 90
Chandler 54
Cambridge 41
Ashburn 33
Woodbridge 33
Seattle 30
Houston 29
Wilmington 14
San Diego 11
Helsinki 10
Dubai 9
Ann Arbor 8
Medford 8
Princeton 8
Boardman 6
Roxbury 6
Des Moines 5
Nagasaki 5
Nanjing 5
Crotone 4
Glasgow 4
Padova 4
Beijing 3
Dearborn 3
Kunming 3
Milan 3
Trieste 3
Chandigarh 2
Johannesburg 2
Legnaro 2
Taipei 2
Bolzano 1
Botucatu 1
Camponogara 1
Dublin 1
Faisalabad 1
Irving 1
Islington 1
Ljubljana 1
Los Angeles 1
Madrid 1
Malmo 1
Mays Landing 1
Norwalk 1
Nürnberg 1
Pangkalpinang 1
Queens 1
Radeberg 1
Scarborough 1
Toronto 1
Verona 1
Vicoforte 1
Vári 1
Washington 1
Xian 1
Totale 464
Nome #
The isoquinoline alkaloid berberine inhibits human cytomegalovirus replication by interfering with the viral Immediate Early-2 (IE2) protein transactivating activity 127
Repurposing the clinically approved calcium antagonist manidipine dihydrochloride as a new early inhibitor of human cytomegalovirus targeting the Immediate-Early 2 (IE2) protein 89
Drug Repurposing Campaigns for Human Cytomegalovirus Identify a Natural Compound Targeting the Immediate-Early 2 (IE2) Protein: A Comment on "The Natural Flavonoid Compound Deguelin Inhibits HCMV Lytic Replication within Fibroblasts" 80
The antifungal drug isavuconazole inhibits the replication of human cytomegalovirus (HCMV) and acts synergistically with anti-HCMV drugs 71
The Clinically Approved Antifungal Drug Posaconazole Inhibits Human Cytomegalovirus Replication 53
The cranberry extract Oximacro® prevents Hazara virus infection by inhibiting the attachment to target cells 47
Cranberry (Vaccinium macrocarpon) Extract Impairs Nairovirus Infection by Inhibiting the Attachment to Target Cells 37
IN VITRO ANTIVIRAL ACTIVITY OF A CRANBERRY VACCINIUM MACROCARPON EXTRACT AGAINST EBOLA VIRUS AND RABIES VIRUS 34
The proanthocyanidin-rich compound Oximacro® affects the early stages of HIV-1 replication 33
Tackling the Future Pandemics: Broad-Spectrum Antiviral Agents (BSAAs) Based on A-Type Proanthocyanidins 3
Totale 574
Categoria #
all - tutte 1.978
article - articoli 1.590
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.568


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201926 0 0 0 0 0 0 0 6 0 5 9 6
2019/2020103 6 3 13 6 11 9 17 10 15 7 4 2
2020/2021137 2 3 6 6 6 3 4 2 19 16 14 56
2021/2022115 5 9 12 18 9 7 7 13 0 10 2 23
2022/2023107 21 9 3 14 17 18 2 5 7 2 6 3
2023/202478 5 29 15 10 19 0 0 0 0 0 0 0
Totale 574